These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26125761)

  • 1. Ara-C and anti-CD47 antibody combination therapy eliminates acute monocytic leukemia THP-1 cells in vivo and in vitro.
    Wang Y; Yin C; Feng L; Wang C; Sheng G
    Genet Mol Res; 2015 May; 14(2):5630-41. PubMed ID: 26125761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness of anti-CD47 antibody and Ara-C combination targeting therapy NOD/SCID mouse of myeloid leukemia].
    Wang YC; Feng L; Yin CY; Ma LN; Wei YW; Wang CM; Sheng GY
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jul; 15(7):577-82. PubMed ID: 23866283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sorting, identification and enrichment of side population cells in THP-1 acute monocytic leukemia cells.
    Wang Y; Yin C; Feng L; Ma L; Wei Y; Sheng G
    Oncol Rep; 2013 May; 29(5):1923-31. PubMed ID: 23450319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of a monoclonal antibody against CD47 in xenograft models of human leukemia.
    Uno S; Kinoshita Y; Azuma Y; Tsunenari T; Yoshimura Y; Iida S; Kikuchi Y; Yamada-Okabe H; Fukushima N
    Oncol Rep; 2007 May; 17(5):1189-94. PubMed ID: 17390064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer.
    Yoshida K; Tsujimoto H; Matsumura K; Kinoshita M; Takahata R; Matsumoto Y; Hiraki S; Ono S; Seki S; Yamamoto J; Hase K
    Cancer Med; 2015 Sep; 4(9):1322-33. PubMed ID: 26077800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron Oxide Nanoparticles Combined with Cytosine Arabinoside Show Anti-Leukemia Stem Cell Effects on Acute Myeloid Leukemia by Regulating Reactive Oxygen Species.
    Dou J; Li L; Guo M; Mei F; Zheng D; Xu H; Xue R; Bao X; Zhao F; Zhang Y
    Int J Nanomedicine; 2021; 16():1231-1244. PubMed ID: 33633448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bispecific antibody targeting CD47 and CD20 selectively binds and eliminates dual antigen expressing lymphoma cells.
    Piccione EC; Juarez S; Liu J; Tseng S; Ryan CE; Narayanan C; Wang L; Weiskopf K; Majeti R
    MAbs; 2015; 7(5):946-56. PubMed ID: 26083076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells.
    Tahk S; Vick B; Hiller B; Schmitt S; Marcinek A; Perini ED; Leutbecher A; Augsberger C; Reischer A; Tast B; Humpe A; Jeremias I; Subklewe M; Fenn NC; Hopfner KP
    J Hematol Oncol; 2021 Sep; 14(1):155. PubMed ID: 34579739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble extracellular domains of human SIRPα and CD47 expressed in Escherichia coli enhances the phagocytosis of leukemia cells by macrophages in vitro.
    Lin Y; Yan XQ; Yang F; Yang XW; Jiang X; Zhao XC; Zhu BK; Liu L; Qin HY; Liang YM; Han H
    Protein Expr Purif; 2012 Sep; 85(1):109-16. PubMed ID: 22813925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CD47 and leukemia stem cells].
    Cheng QS; Wang XB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1088-91. PubMed ID: 20723335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo.
    Zhang M; Hutter G; Kahn SA; Azad TD; Gholamin S; Xu CY; Liu J; Achrol AS; Richard C; Sommerkamp P; Schoen MK; McCracken MN; Majeti R; Weissman I; Mitra SS; Cheshier SH
    PLoS One; 2016; 11(4):e0153550. PubMed ID: 27092773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.
    Majeti R; Chao MP; Alizadeh AA; Pang WW; Jaiswal S; Gibbs KD; van Rooijen N; Weissman IL
    Cell; 2009 Jul; 138(2):286-99. PubMed ID: 19632179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells.
    Kim D; Wang J; Willingham SB; Martin R; Wernig G; Weissman IL
    Leukemia; 2012 Dec; 26(12):2538-45. PubMed ID: 22648449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New approaches to target leukemia stem cells].
    Takenaka K; Akashi K
    Nihon Rinsho; 2014 Jun; 72(6):1018-25. PubMed ID: 25016798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma.
    Xiao Z; Chung H; Banan B; Manning PT; Ott KC; Lin S; Capoccia BJ; Subramanian V; Hiebsch RR; Upadhya GA; Mohanakumar T; Frazier WA; Lin Y; Chapman WC
    Cancer Lett; 2015 May; 360(2):302-9. PubMed ID: 25721088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD47 blockade inhibits tumor progression human osteosarcoma in xenograft models.
    Xu JF; Pan XH; Zhang SJ; Zhao C; Qiu BS; Gu HF; Hong JF; Cao L; Chen Y; Xia B; Bi Q; Wang YP
    Oncotarget; 2015 Sep; 6(27):23662-70. PubMed ID: 26093091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CD47 antibody suppresses tumour growth and augments the effect of chemotherapy treatment in hepatocellular carcinoma.
    Lo J; Lau EY; So FT; Lu P; Chan VS; Cheung VC; Ching RH; Cheng BY; Ma MK; Ng IO; Lee TK
    Liver Int; 2016 May; 36(5):737-45. PubMed ID: 26351778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new disulfide-linked dimer of a single-chain antibody fragment against human CD47 induces apoptosis in lymphoid malignant cells via the hypoxia inducible factor-1α pathway.
    Sagawa M; Shimizu T; Fukushima N; Kinoshita Y; Ohizumi I; Uno S; Kikuchi Y; Ikeda Y; Yamada-Okabe H; Kizaki M
    Cancer Sci; 2011 Jun; 102(6):1208-15. PubMed ID: 21401803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells.
    Majeti R
    Oncogene; 2011 Mar; 30(9):1009-19. PubMed ID: 21076471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fully human anti-CD47 blocking antibody with therapeutic potential for cancer.
    Zeng D; Sun Q; Chen A; Fan J; Yang X; Xu L; Du P; Qiu W; Zhang W; Wang S; Sun Z
    Oncotarget; 2016 Dec; 7(50):83040-83050. PubMed ID: 27863402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.